SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

DALPIAZ, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.428
AS - Asia 9.964
EU - Europa 4.977
SA - Sud America 1.617
AF - Africa 208
OC - Oceania 25
Continente sconosciuto - Info sul continente non disponibili 9
AN - Antartide 1
Totale 33.229
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.096
SG - Singapore 3.700
CN - Cina 2.432
BR - Brasile 1.243
VN - Vietnam 1.056
UA - Ucraina 992
HK - Hong Kong 864
IT - Italia 818
DE - Germania 740
TR - Turchia 597
GB - Regno Unito 536
FR - Francia 371
FI - Finlandia 340
SE - Svezia 305
JP - Giappone 292
IN - India 286
RU - Federazione Russa 258
PL - Polonia 239
MX - Messico 153
CA - Canada 138
AR - Argentina 136
BD - Bangladesh 126
ID - Indonesia 109
PK - Pakistan 81
NL - Olanda 80
CO - Colombia 73
ZA - Sudafrica 67
IQ - Iraq 65
EC - Ecuador 52
ES - Italia 52
AT - Austria 40
CL - Cile 38
UZ - Uzbekistan 38
LT - Lituania 36
BE - Belgio 35
IR - Iran 35
PH - Filippine 34
SA - Arabia Saudita 31
CZ - Repubblica Ceca 29
TW - Taiwan 29
EG - Egitto 27
MA - Marocco 26
PY - Paraguay 26
VE - Venezuela 26
AE - Emirati Arabi Uniti 25
MY - Malesia 24
KR - Corea 23
KE - Kenya 21
TN - Tunisia 20
IE - Irlanda 16
TH - Thailandia 16
AU - Australia 15
DZ - Algeria 14
NP - Nepal 13
PE - Perù 12
AL - Albania 11
LB - Libano 10
NZ - Nuova Zelanda 10
CH - Svizzera 9
ET - Etiopia 9
KZ - Kazakistan 9
AZ - Azerbaigian 8
BG - Bulgaria 8
DO - Repubblica Dominicana 8
IL - Israele 8
JO - Giordania 8
PS - Palestinian Territory 8
RO - Romania 8
RS - Serbia 8
CR - Costa Rica 7
BO - Bolivia 6
HU - Ungheria 6
JM - Giamaica 6
QA - Qatar 6
BA - Bosnia-Erzegovina 5
CI - Costa d'Avorio 5
DK - Danimarca 5
HN - Honduras 5
KG - Kirghizistan 5
OM - Oman 5
PT - Portogallo 5
SY - Repubblica araba siriana 5
GE - Georgia 4
GR - Grecia 4
MK - Macedonia 4
NO - Norvegia 4
XK - ???statistics.table.value.countryCode.XK??? 4
BY - Bielorussia 3
EU - Europa 3
GT - Guatemala 3
KW - Kuwait 3
ME - Montenegro 3
MN - Mongolia 3
NG - Nigeria 3
PA - Panama 3
SC - Seychelles 3
SN - Senegal 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
Totale 33.196
Salva come PNG Salva come JPEG
Città #
Singapore 2.318
Ashburn 1.726
Woodbridge 1.461
Fairfield 1.340
Jacksonville 1.016
Houston 1.011
San Jose 930
Chandler 855
Hong Kong 840
Santa Clara 780
Beijing 699
Ann Arbor 622
Wilmington 559
Seattle 535
Cambridge 480
Ho Chi Minh City 374
Izmir 338
Nanjing 299
Hanoi 271
Tokyo 265
Ferrara 232
Princeton 227
Warsaw 226
Los Angeles 209
New York 209
Dallas 191
Boardman 189
Lauterbourg 188
The Dalles 149
Milan 123
San Diego 121
Munich 117
Helsinki 110
São Paulo 109
Addison 104
Nanchang 99
Mexico City 91
Council Bluffs 86
Shenyang 81
Hefei 77
Orem 77
Shanghai 76
Hebei 74
London 69
Jakarta 65
Tianjin 64
Brooklyn 55
Rio de Janeiro 55
Changsha 54
Chicago 53
Falls Church 49
Bremen 47
Chennai 47
Frankfurt am Main 47
Moscow 47
Redwood City 46
San Mateo 46
Dearborn 44
Montreal 43
Buffalo 40
Da Nang 40
Turku 38
Amsterdam 37
Jiaxing 35
Kunming 35
Falkenstein 34
Tashkent 34
Johannesburg 33
Norwalk 33
Stockholm 32
Atlanta 31
Toronto 31
Denver 30
Ankara 28
Manchester 28
Mountain View 28
Haiphong 27
Jinan 27
Belo Horizonte 26
Phoenix 26
San Francisco 26
Bologna 25
Medellín 25
Poplar 25
Dhaka 24
Guangzhou 24
Hải Dương 24
Vienna 24
Boston 23
Brussels 23
Chongqing 23
Nuremberg 23
Zhengzhou 23
Philadelphia 22
Rome 22
Washington 22
Baghdad 21
Mumbai 21
Porto Alegre 20
Biên Hòa 19
Totale 21.847
Salva come PNG Salva come JPEG
Nome #
C- and N-terminal residue effect on peptide derivatives' antagonism toward the formyl-peptide receptor 374
Application of the “in-oil nanoprecipitation” method in the encapsulation of hydrophilic drugs in PLGA nanoparticles 280
Indomethacin co-crystals and their parent mixtures: does the intestinal barrier recognize them differently? 278
A novel hybrid drug between two potent anti-tubulin agents as a potential prolonged anticancer approach 271
Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles 255
Geraniol pharmacokinetics, bioavailability and its multiple effects on the liver antioxidant and xenobiotic-metabolizing enzymes 248
Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapeutic effects of potentially central active drugs 245
Nose-to-brain delivery of antiviral drugs: A way to overcome their active efflux? 245
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 239
Conjugation of aspirin with vitamin C: uptake and stability studies 235
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives. 230
Design, synthesis and in vitro evaluation on HRPE cells of ascorbic and 6-bromoascorbic acid conjugates with neuroactive molecules 220
Design, synthesis and activity of ascorbic acid prodrugs of nipecotic, kynurenic and diclophenamic acids, liable to increase neurotropic activity 217
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands 214
A concerted binding study using binding measurements, X-ray structural data and molecular modeling on the stereochemical features responsible for the affinity of 6-arylpyrrolo[2,1-d][1,5]benzothiazepines to mitochondrial benzodiazepine receptors 213
Responses of peripheral blood mononucleated cells from non-celiac gluten sensitive patients to various cereal sources 211
Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery 211
Physicochemical stability of cabazitaxel and docetaxel solutions 210
Transporter-mediated effects of diclofenamic acid and its ascorbyl pro-drug in the in vivo neurotropic activity of ascorbyl nipecotic acid conjugate 204
Allosteric modulation, thermodynamics and binding to wild-type and mutant (T277A) adenosine A 1 receptors of LUF5831, a novel nonadenosine-like agonist 203
Brain Targeting of an Antiischemic Agent by Nasal Administration of Microparticles 202
An RPE cell line as a useful in vitro model for studying retinoic acid receptor beta: expression and affinity. 200
Development and characterization of PLGA nanoparticles as delivery systems of a prodrug of zidovudine obtained by its conjugation with ursodeoxycholic acid 200
Binding thermodynamics of 5-HT(1A) receptor ligands 200
1H-pyrazolo[4,3-d]pyrimidine-7(6H)-one and 5H-pyrazolo[4,3-d] 1,2,3-triazin-4(3H)-one derivatives. Synthesis and in vitro biological activity at adenosine A1 and A2a receptors 200
Brain uptake of a Zidovudine prodrug after nasal administration of solid lipid microparticles 199
Receptor binding thermodynamics as a tool for linking drug efficacy and affinity 198
Binding thermodynamics at A1 and A2A adenosine receptors 197
Met-Ile-Phe-Leu derivatives: full and partial agonists of human neutrophil formylpeptide receptors 196
Expression and characterization of vitamin C transporter in the human trophoblast cell line HTR-8/SVneo: Effect of steroids, flavonoids and NSAIDs 195
Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries 195
Conformational Aspects of Human Formyl-peptide Receptor Agonists 193
From Physical Mixtures to Co-Crystals: How the Coformers Can Modify Solubility and Biological Activity of Carbamazepine 193
Characterisation of potential adenosine A1 receptor prodrugs of adenosine derivatives with antiischemic properties 192
Phe-D-Leu-Phe-D-Leu-Phe derivatives as formylpeptide receptor antagonists in human neutrophils: cellular and conformational aspects 189
Conformational aspects of human formylpeptide receptor antagonists 186
[3H] CGS 21680 binding to purified adenosine A2A receptors in human platelets 185
Controlled release studies of antiischemic agents encapsulated in poly(lactic acid) nanoparticles. 184
Brain targeting of neuroactive drugs: studies of their transport mechanisms as conjugated with vitamin C or glucose. 183
Dopamine-sensitive adenylyl cyclases in neuronal development: Physiopathological and pharmacological implications 183
Solid lipid microparticles for the stability enhancement of a dopamine prodrug 179
Can pharmaceutical co-crystals provide an opportunity to modify the biological properties of drugs? 178
Hyaluronic acid based-hybrid nanoparticles for targeted nose- to-brain delivery of dimethyl fumarate 177
Binding therodynamics and intrinsic activity of adenosine A1 receptor ligands: a model of their heart rate inhibition power. 177
Uptake in the Central Nervous System of Geraniol Oil Encapsulated in Chitosan Oleate Following Nasal and Oral Administration 177
Solid microparticles based on chitosan or methyl-beta-cyclodextrin: A first formulative approach to increase the nose-to-brain transport of deferoxamine mesylate 177
Progress in drug delivery to the central nervous system by the prodrug approach 176
Exploring the use of spray congealing to produce solid dispersions with enhanced indomethacin bioavailability: In vitro characterization and in vivo study 175
Vitamin C and 6-amino-vitamin C conjugates of diclofenac: synthesis and evaluation 174
Oxcarbazepine free or loaded PLGA nanoparticles as effective intranasal approach to control epileptic seizures in rodents 173
Binding thermodynamics as a tool to investigate the mechanisms of drug-receptor interactions: Thermodynamics of cytoplasmic steroid/nuclear receptors in comparison with membrane receptors 172
[3H] SCH 58261 labels adenosine A2A receptors in human lymphocyte membranes 172
Cationic liposomes carrying anti herpetic peptides as potential ocular vaccine 171
Polymeric nanoparticles as drug controlled release systems: a new formulation strategy for drugs with small or large molecular weight 170
Molecular mechanism involved in the transport of a prodrug dopamine glycosyl conjugate 169
Adenosine analogs prodrugs: design, synthesis and chemico-physical characterization of N6-cyclopentyladenosine (CPA) derivatives 169
Incorporation of the polar antiischemic drug N6-cyclopentyladenosine in solid lipid microparticles 169
[3H] CGS 21680 binding to purified adenosine A2A receptors in human platelets 169
Binding thermodynamics of adenosine A2a receptor ligands 167
N-ureido peptide derivatives as antagonists towar human neutrophil formylpeptide receptor 166
Poly(lactic acid) microspheres for the sustained release of antiischemic agents 165
Can Thermodynamic Measurements of Receptor Binding Yield Information on Drug Affinity and Efficacy? 165
Synthesis and biological evaluation of pro-drugs of GW196771, a potent glycine antagonist acting at the NMDA receptor 163
Particulate formulations based on chitosan for nose-to-brain delivery of drugs. A review 163
Bile acids modulation of nanoparticle macrophage uptake 162
Complementary use of flow and sedimentation field-flow fractionation techniques for size characterizing biodegradable poly(lactic acid) nanospheres 160
[3H] SCH 58261 labels adenosine A2A receptors in human lymphocyte membranes 160
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 159
Full and partial agonists and thermodynamic binding parameters of adenosine A1 receptor ligands 157
Peptide derivatives as agonists or antagonists of formylpeptide receptors: analysis of their effects on neutrophils 157
A Novel Conjugated Agent between Dopamine and an A(2A) Adenosine Receptor Antagonist as a Potential Anti-Parkinson Multitarget Approach. 157
Effect of chronic caffeine intake on A2A adenosine receptors in human neutrophils. 155
Caffeine intake induces an alteration of human neutrophils A2A adenosine receptors. 155
Potential therapeutic effects of odorants through their ectopic receptors in pigmented cells 155
Design and formulation of Eudragit-coated zein/pectin nanoparticles for the colon delivery of resveratrol 155
Effects of Microencapsulated Ferulic Acid or Its Prodrug Methyl Ferulate on Neuroinflammation Induced by Muramyl Dipeptide 155
Binding thermodynamics and intrinsic activity of adenosine A1 receptor ligands: a model of their heart rate inhibition power. 154
Chlorogenic acid permeation across intestinal cell monolayers: influence by circadian rhythms in the presence of other natural polyphenols and by dopaminergic neuronal-like cells 154
Evidence for the presence of N-formyl-methionyl-leucyl-phenylalanine (fMLP) receptor ligands in human amniotic fluid and fMLP receptor modulation by physiological labour 153
Studies on human neutrophil biological functions by means of formylpeptide receptor agonists and antagonists 153
Thermodynamics of full agonist, partial agonist, and antagonist binding to wild-type and mutant adenosine A1 receptors 153
Drug release from pharmaceutical co-crystals: Are therapeutic and safety properties of active pharmaceutical substances retained? 153
Cancer stem cells and nanomedicine: new opportunities to combat multidrug resistance? 153
Adenosine A1 receptor: Analysis of the potential therapeutic effects obtained by its activation in the central nervous system 153
Quantitative determination of zolmitriptan in rat blood and cerebrospinal fluid by reversed phase HPLC-ESI-MS/MS analysis: application to in-vivo preclinical pharmacokinetic study 152
Prodrugs and Endogenous Transporters: Are They Suitable Tools for Drug Targeting into the Central Nervous System? 151
From crystal to solution and across the membranes: the case of carbamazepine co-crystals 151
Exploring the Use of Spray Congealing to Produce Solid Dispersions with Enhanced Indomethacin Bioavailability 151
Chlorogenic acid permeation across intestinal cell monolayers: Influence by circadian rhythms in the presence of other natural polyphenols and by dopaminergic neuronal-like cells 150
Nasal administration and brain targeting of an antiischemic agent 150
Determination of the adenosine A1 agonist N6-cyclopentyladenosine in rat blood by solid-phase extraction and HPLC 149
Temperature dependence and GABA modulation of β-carboline binding to rat cerebellum benzodiazepine receptors 149
Uptake and stability studies of diclofenamic acid and its pro-drug obtained by conjugation with vitamin C 149
Coniugati dell’acido ascorbico ad attività neurotropica. 149
Characterization and Hydrolysis Studies of a Prodrug Obtained as Ester Conjugate of Geraniol and Ferulic Acid by Enzymatic Way 147
Neuroactive molecules and their pro-drugs obtained by conjugation with vitamin c: studies of delivery into the brain. 146
Risedronate pharmacokinetic studies after oral administration to rats of loaded TiO2 nanoparticles 146
Materie Prime: Eccipienti 145
Cocrystals of Nitrofurantoin: How Coformers Can Modify Its Solubility and Permeability Across Intestinal Cell Monolayers 145
Biochemical and pharmacological characterization of periodate-oxidized adenosine analogues at adenosine A1 receptors. 142
Totale 18.271
Salva come PNG Salva come JPEG
Categoria #
all - tutte 142.033
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.331
Totale 145.364
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021943 0 0 0 0 0 0 0 0 0 446 366 131
2021/20221.984 50 229 148 121 88 85 77 105 76 164 182 659
2022/20231.979 227 94 53 256 380 308 59 156 250 15 115 66
2023/2024994 121 133 57 24 94 111 35 39 15 19 33 313
2024/20254.803 98 91 382 190 613 431 192 295 726 583 712 490
2025/202612.404 1.245 583 1.173 1.706 1.767 842 1.474 813 1.420 1.381 0 0
Totale 33.552